Sibling-based association study of the PPARγ2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families:: a SAPPHIRe study

被引:40
作者
Chuang, LM
Hsiung, CA
Chen, YDI
Ho, LT
Sheu, WHH
Pei, D
Nakatsuka, CH
Cox, D
Pratt, RE
Lei, HH
Tai, TY
机构
[1] Natl Taiwan Univ Hosp, Dept Med, Taipei, Taiwan
[2] Natl Hlth Res Inst, Div Biostat & Bioinformat, Taipei, Taiwan
[3] Vet Gen Hosp, Dept Med, Taipei, Taiwan
[4] Taichung Vet Gen Hosp, Dept Endocrinol & Metab, Taichung, Taiwan
[5] Triserv Gen Hosp, Dept Endocrinol & Metab, Taipei, Taiwan
[6] Kaiser Permanente Hawaii, Honolulu, HI USA
[7] Stanford Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Stanford, CA 94305 USA
[8] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA
[9] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2001年 / 79卷 / 11期
关键词
peroxisome proliferator activated receptor gamma(2); gene polymorphism; insulin sensitivity; sibling-based association study; hypertension;
D O I
10.1007/s001090100255
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The peroxisome proliferator activated receptor (PPAR) gamma (2) is a transcription factor that has been shown to be involved in adipocyte differentiation, adipogenesis., and insulin sensitivity. To address the role of PPAR gamma (2) in glucose homeostasis and insulin sensitivity, among many other objectives, we conducted a sibling-controlled association study in a multicenter program - the Stanford Asian-Pacific Program in Hypertension and Insulin Resistance (SAPPHIRe). Approximately 2525 subjects in 734 Chinese and Japanese families have been recruited from six field centers for SAPPHIRe. In total, 1702 subjects including parents and siblings from 449 families have been genotyped for PPAR gamma (2), of which 328 families were Chinese and 121 Japanese. Only 88 subjects of the 1525 siblings screened for the P12A polymorphism were found to be carriers of the A variant, the most common variant of the PPAR gamma (2) gene. A variant frequencies of the siblings were 4.27% in Chinese and 2.72% in Japanese. A sibling-controlled association study was performed through genetically discordant sibships (i.e., P/P genotype vs. P/A + A/A genotypes). Specifically, we examined whether there were differences in metabolic variables between the discordant siblings within families. In total, 88 subjects carrying either 1 or 2 A alleles had at least one sibling who was discordant for the P12A polymorphism, yielding a total of 180 individuals from 47 families for analyses, among which 92 siblings were homozygous for wild-type P allele. Siblings with the A variant tended to have tower levels of fasting plasma glucose (OG-10), and lower glucose levels at 60 min following oral glucose loading after adjusting for age, gender, and body mass index. Using a mixed model treating family as a random effect, we found that P12A polymorphism of the PPAR gamma (2) gene contributes significantly to the variance in fasting plasma glucose, glucose level at 60 min, and insulin-resistance homeostasis model assessment. Our results suggest that within families siblings with the A variant in the PPAR gamma (2) gene may be more likely to have better glucose tolerance and insulin sensitivity independent of obesity in Chinese and Japanese populations.
引用
收藏
页码:656 / 664
页数:9
相关论文
共 34 条
[1]   The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes [J].
Altshuler, D ;
Hirschhorn, JN ;
Klannemark, M ;
Lindgren, CM ;
Vohl, MC ;
Nemesh, J ;
Lane, CR ;
Schaffner, SF ;
Bolk, S ;
Brewer, C ;
Tuomi, T ;
Gaudet, D ;
Hudson, TJ ;
Daly, M ;
Groop, L ;
Lander, ES .
NATURE GENETICS, 2000, 26 (01) :76-80
[2]   PPARγ, the ultimate thrifty gene [J].
Auwerx, J .
DIABETOLOGIA, 1999, 42 (09) :1033-1049
[3]   PPARγ is required for placental, cardiac, and adipose tissue development [J].
Barak, Y ;
Nelson, MC ;
Ong, ES ;
Jones, YZ ;
Ruiz-Lozano, P ;
Chien, KR ;
Koder, A ;
Evans, RM .
MOLECULAR CELL, 1999, 4 (04) :585-595
[4]   Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension [J].
Barroso, I ;
Gurnell, M ;
Crowley, VEF ;
Agostini, M ;
Schwabe, JW ;
Soos, MA ;
Maslen, GL ;
Williams, TDM ;
Lewis, H ;
Schafer, AJ ;
Chatterjee, VKK ;
O'Rahilly, S .
NATURE, 1999, 402 (6764) :880-883
[5]   Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR gamma) gene [J].
Beamer, BA ;
Negri, C ;
Yen, CJ ;
Gavrilova, O ;
Rumberger, JM ;
Durcan, MJ ;
Yarnall, DP ;
Hawkins, AL ;
Griffin, CA ;
Burns, DK ;
Roth, J ;
Reitman, M ;
Shuldiner, AR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (03) :756-759
[6]   Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations [J].
Beamer, BA ;
Yen, CJ ;
Andersen, BE ;
Muller, D ;
Elahi, D ;
Cheskin, LJ ;
Andres, R ;
Roth, J ;
Shuldiner, AR .
DIABETES, 1998, 47 (11) :1806-1808
[7]   Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells [J].
Brockman, JA ;
Gupta, RA ;
DuBois, RN .
GASTROENTEROLOGY, 1998, 115 (05) :1049-1055
[8]   Use of siblings as controls in case-control association studies [J].
Curtis, D .
ANNALS OF HUMAN GENETICS, 1997, 61 :319-333
[9]   Thiazolidinediones: a new class of antidiabetic drugs [J].
Day, C .
DIABETIC MEDICINE, 1999, 16 (03) :179-192
[10]   A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity [J].
Deeb, SS ;
Fajas, L ;
Nemoto, M ;
Pihlajamäki, J ;
Mykkänen, L ;
Kuusisto, J ;
Laakso, M ;
Fujimoto, W ;
Auwerx, J .
NATURE GENETICS, 1998, 20 (03) :284-287